Can You Have Tachycardia With a Pacemaker?

Tachycardia can absolutely occur in someone with a pacemaker, and it happens through more pathways than most people realize. A pacemaker’s core job is preventing the heart from beating too slowly, but several mechanisms can drive the heart rate uncomfortably fast in pacemaker patients. Some of these fast rhythms originate in the heart itself, some are created by the pacemaker’s own circuitry, and in rare cases, hardware failure can produce dangerously rapid pacing. Understanding how and why matters, because the type of tachycardia determines whether your doctor needs to reprogram the device, adjust medications, or intervene more urgently.

The Pacemaker Can Cause Tachycardia Itself

The most distinctive form of tachycardia in pacemaker patients is one the device actually creates. Called pacemaker-mediated tachycardia (PMT), it is a well-recognized complication of dual-chamber pacemakers, which sense and pace both the upper chambers (atria) and lower chambers (ventricles). PMT results from the atrial sensing circuit picking up retrograde P waves or ectopic atrial activity and then triggering a ventricular pacing pulse in response.¹ In plain terms, the pacemaker senses an electrical signal bouncing backward from the ventricle to the atrium, interprets it as a real atrial beat, and paces the ventricle again. That ventricular pacing pulse then bounces back to the atrium, the pacemaker senses it again, and a self-sustaining loop forms.

Most of these episodes begin with a premature ventricular contraction, a common extra heartbeat that sends an electrical signal backward through the heart’s conduction system.² But PMT can also start after a normally timed heartbeat if the device’s atrial refractory interval is set shorter than the time it takes for electrical signals to travel backward from ventricle to atrium.³ For the person experiencing it, PMT feels like a sudden onset of rapid heartbeat, sometimes with lightheadedness or palpitations. The rate typically reaches whatever the pacemaker’s programmed upper tracking limit is, which might be anywhere from 110 to 130 beats per minute, though it can sometimes sustain below that ceiling.

Why Dual-Chamber Devices Are More Vulnerable

Single-chamber pacemakers, which pace only the ventricle or only the atrium, rarely produce PMT because the feedback loop requires sensing in one chamber and pacing in the other. The problem is inherent to dual-chamber designs (DDD mode), where the device is programmed to sense atrial activity and use it to time ventricular pacing. This “tracking” behavior is actually desirable during normal function, because it preserves the natural coordination between the upper and lower chambers. But it also creates an opening for the device to chase signals it was never meant to follow.

Dual-chamber rate-responsive pacemakers (DDDR mode) add another layer. These devices have both a maximum tracking rate, which limits how fast they will pace the ventricle in response to sensed atrial activity, and a separate maximum sensor rate, which limits how fast the built-in motion or metabolic sensor can drive pacing.⁴ If these two limits are programmed at different values, the device can behave in ways that surprise both the patient and the clinician. The upper rate limit is a programmable safeguard that prevents the ventricle from being paced too fast, but reaching it repeatedly during daily activities can itself cause symptoms from abrupt changes in pacing behavior.

Your Own Heart Rhythm Can Still Go Fast

A pacemaker does not replace the heart’s natural electrical system. It supplements it. If your atria develop an arrhythmia like atrial fibrillation or atrial flutter, those chaotic signals are still happening in your heart tissue. In a dual-chamber pacemaker, the atrial lead can sense those rapid signals and, unless the device intervenes, track them down to the ventricle. Without safeguards, a patient with atrial fibrillation running at 200 or more beats per minute in the atria could end up with the pacemaker driving the ventricle dangerously fast.

Modern dual-chamber pacemakers address this with automatic mode switching (AMS). When the device detects sustained rapid atrial activity, it temporarily switches from a tracking mode (where it follows atrial signals) to a non-tracking mode (where it ignores them and paces the ventricle independently at a safe rate).⁵ AMS has been validated against continuous Holter monitoring and tracks atrial fibrillation duration with strong accuracy.⁶ But AMS is not instantaneous. There can be a brief delay before the algorithm kicks in, during which a burst of fast ventricular pacing occurs. And if the AMS sensitivity or detection criteria are programmed too conservatively, it may fail to switch at all during borderline episodes.

Even with AMS working perfectly, the underlying atrial fibrillation itself is still present. The pacemaker is managing the ventricular response, not curing the arrhythmia. Patients with pacemakers who develop atrial fibrillation still need the same evaluation and treatment, including decisions about anticoagulation, that anyone else with atrial fibrillation would need.

Ventricular Tachycardia in Pacemaker Patients

Ventricular tachycardia, a fast rhythm originating in the lower chambers of the heart, can occur in anyone with structural heart disease, and many pacemaker recipients have exactly that. Having a pacemaker does not protect against ventricular tachycardia. In patients with implantable cardioverter-defibrillators (ICDs), which combine pacemaker function with the ability to shock dangerous rhythms, spontaneous ventricular tachyarrhythmias are common enough that large studies have documented tens of thousands of episodes, with device therapy successfully terminating roughly 98% of them.⁷

For patients with standard pacemakers (without defibrillator capability), ventricular tachycardia is a more concerning scenario because the device cannot deliver a shock. Pacemaker diagnostics can log ventricular high-rate episodes, and these episodes are clinically meaningful. In patients with tachy-brady syndrome, where the heart alternates between going too slowly and too quickly, ventricular high-rate episodes detected by the pacemaker were an independent predictor of hospitalization for cardiovascular symptoms, roughly tripling the odds even after accounting for the burden of atrial arrhythmias and underlying heart disease.⁸

There is also evidence that pacing itself can, paradoxically, promote ventricular arrhythmias in some patients. In one case report involving a leadless pacemaker, premature ventricular contractions triggered polymorphic ventricular tachycardia through a short-long-short sequence, where a PVC followed by a paced beat at the backup rate created the conditions for a dangerous R-on-T phenomenon.⁹ The problem was resolved by repositioning the device. Separately, cumulative right ventricular pacing above 2% of the time was associated with significantly shorter time to heart failure events and was an independent predictor of those events in ICD patients.¹⁰ This has led to programming strategies that minimize unnecessary right ventricular pacing whenever possible.

Runaway Pacemaker

The most alarming form of pacemaker-related tachycardia is the runaway pacemaker, a rare hardware malfunction in which the device fires at wildly rapid, non-physiological rates. Documented cases have recorded pacing spikes at rates as high as 2,000 to 2,600 pulses per minute, far beyond anything the heart could follow.¹¹ These episodes typically alternate with normal pacing, producing bursts of rapid stimuli lasting a few seconds at a time.

Runaway episodes are usually linked to low battery voltage. The earliest reported case, from 1965, was traced to a failed transistor in the timing circuit and a voltage leak from a defective output capacitor.¹² Modern devices have improved safeguards, including better battery monitoring, but runaway remains a recognized failure mode that clinicians need to keep in mind, especially in devices approaching end of battery life.¹³ Patients typically present with dizziness or near-fainting episodes. Fortunately, the runaway stimuli are often too weak to actually capture the heart muscle, meaning the heart does not follow every erratic spike. The fix is straightforward: emergency replacement of the pulse generator.

Oversensing and False Signals

A pacemaker depends on its ability to sense the heart’s electrical signals accurately. When it senses signals that are not real heartbeats, the consequences depend on the pacing mode. In demand pacing, oversensing can cause the device to withhold pacing when it should be pacing, because it believes the heart is already beating. But in a tracking mode, oversensing of something the atrial lead picks up can trigger ventricular pacing, producing an inappropriately rapid heart rate.

Muscle signals are a common culprit. In unipolar pacemakers, myopotential oversensing during arm movements or physical exertion was found in nearly half of patients performing a reach maneuver in one study, with the susceptibility varying widely between manufacturers.¹⁴ Bipolar lead configurations reduce this problem substantially, but do not eliminate it entirely. Diaphragmatic myopotentials, the electrical signals produced by the breathing muscle, have caused inappropriate arrhythmia detection in defibrillators as well, leading to unnecessary shock deliveries in some patients.¹⁵

Electromagnetic interference from external sources can also produce false signals that the device misinterprets. The growing number of electronic devices in daily life, from security systems to industrial equipment, creates more potential sources of interference for cardiac implanted electronic devices.¹⁶ Whether this causes tachycardia or inappropriate inhibition depends on which chamber’s lead picks up the noise and how the device interprets it.

How Devices Try to Prevent and Stop Fast Pacing

Pacemaker engineers have been battling these problems since dual-chamber pacing became widespread. The primary defense against PMT is the post-ventricular atrial refractory period (PVARP), a programmable interval after each ventricular paced beat during which the atrial channel ignores any signals it receives. If the PVARP is set longer than the time it takes for electrical conduction to travel backward from ventricle to atrium, the retrograde signal arrives during the “deaf” window and the loop never forms.¹⁷

But programming PVARP too long creates its own problems. A very long refractory period can limit the maximum tracking rate, meaning the pacemaker cannot keep up during exercise. It can also cause a related issue called repetitive nonreentrant ventriculoatrial synchrony (RNRVAS), where the atrium is paced while still in the refractory period and the pacing pulse fails to capture, creating a repeating pattern of ineffective atrial stimulation. Modern devices include algorithms that detect PMT by recognizing consistent atrial sensing at regular intervals after ventricular pacing and then interrupt the loop, usually by temporarily extending the PVARP or switching modes.

Rate smoothing algorithms, introduced in the 1980s, were designed to reduce sudden changes in heart rate during exercise when the pacemaker hits its upper rate limits. Early versions sometimes created their own problems, including irregular pacemaker-mediated tachycardia and loss of coordination between the upper and lower chambers.¹⁸ Contemporary versions are more refined, but the underlying tradeoff remains: every protective algorithm that limits fast pacing also reduces the device’s ability to respond to the patient’s genuine need for a higher heart rate during physical activity.

When the Device Logs Fast Rhythms You Never Felt

Modern pacemakers quietly record every episode of fast heart rate they detect, creating a diagnostic log that clinicians review during device checks. These atrial high-rate episodes (AHREs) are among the most clinically useful data the device provides, because they can reveal atrial fibrillation that the patient never noticed. But not all AHREs represent true arrhythmias. One analysis of stored electrograms found that about 62% of logged high atrial rate episodes were events other than true atrial tachyarrhythmias, including oversensing, far-field signals, and noise.¹⁹ Episodes with rates above 250 beats per minute lasting longer than five minutes had a much stronger correlation with actual atrial fibrillation or flutter.

This matters because device-detected AHREs can prompt decisions about anticoagulation. If a pacemaker logs episodes that look like atrial fibrillation, the clinical team needs to determine whether those episodes are real before starting blood thinners.²⁰ Longer episodes are more likely to be genuine. Research has found that the longest detected AHRE episode, particularly those lasting 12 hours or more, was a strong independent predictor of progressing to clinical atrial fibrillation.²¹ Short, isolated blips are more likely to be artifact or non-sustained rhythms that may not require treatment.

Sinus Tachycardia Still Happens

It is worth remembering that a pacemaker patient can have a fast heart rate for all the ordinary reasons anyone else can. Fever, dehydration, anxiety, anemia, pain, hyperthyroidism, infection, and even caffeine can drive the sinus node to fire faster than 100 beats per minute. A dual-chamber pacemaker programmed to track the atrium will dutifully follow this elevated sinus rate up to its upper tracking limit, because it is doing exactly what it was designed to do: keeping the ventricle synchronized with the atrium. The resulting fast heart rate is physiologically appropriate, and the pacemaker is functioning correctly.

Some patients develop inappropriately fast sinus rates without any obvious medical trigger. Inappropriate sinus tachycardia and postural tachycardia syndrome (POTS) are among several conditions where the sinus rate rises beyond what the situation warrants. These conditions exist independently of pacemaker status and do not go away because a device has been implanted. The pacemaker may complicate diagnosis somewhat, since the stored electrograms and rate histograms need to be interpreted in context, but the underlying problem is in the sinus node’s behavior, not the hardware.

What to Do If You Feel Your Heart Racing

If you have a pacemaker and notice a sudden sustained fast heartbeat, the appropriate response depends on what else you are feeling. Lightheadedness, chest pain, or shortness of breath with a rapid rate warrants urgent medical evaluation. Even without those symptoms, a new pattern of recurrent palpitations should be reported to your device clinic, because it may indicate PMT, a change in your underlying rhythm, or a programming issue that can be fixed.

Many instances of pacemaker-related tachycardia are resolved with reprogramming alone. Extending the PVARP, adjusting the upper tracking rate, enabling or fine-tuning the PMT termination algorithm, or switching the pacing mode can eliminate episodes without any procedure. For patients with frequent atrial fibrillation causing rapid ventricular rates despite AMS, medications such as beta-blockers or antiarrhythmics may be added. And for the rare runaway pacemaker, the treatment is generator replacement, which is a relatively minor procedure once the problem is identified.

The single most important thing a pacemaker patient can do is keep regular device check appointments. The logs and electrograms stored in the device often reveal tachycardia episodes that the patient never felt, and catching them early allows treatment before they progress or cause complications. Remote monitoring, available with most modern devices, can transmit alerts for high-rate episodes between in-person visits, closing the gap between an event and a clinical response.